Syntax Research, Inc. Merck & Co., Inc. Transaction History
Syntax Research, Inc.
- $141 Billion
- Q2 2025
A detailed history of Syntax Research, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 4,006 shares of MRK stock, worth $339,348. This represents 0.23% of its overall portfolio holdings.
Number of Shares
4,006
Previous 34,034
88.23%
Holding current value
$339,348
Previous $3.05 Billion
89.62%
% of portfolio
0.23%
Previous 2.11%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,888Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$21.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.2 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.92 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$5.05 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $215B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...